Cancer discovery news
Our researchers are making the discoveries that defeat cancer. Read the latest findings from our world-leading research.
Visit our main news hub to read about news on new funding, our fundraising activities and much more. If you want to keep updated on our news, you can follow us on social media or sign up for our Search newsletter.
If you’re a journalist and want to find out more, you can contact our media relations team.
-547x410.jpg?sfvrsn=c727183b_2 "Non-small cell lung cancer (photo Dr Ed Uthman-Yale Rosen-Flickr) 547x410")
Breast cancer drugs could help treat resistant lung cancers
A class of drugs used to treat certain breast cancers could help to tackle lung cancers that have become resistant to targeted therapies, suggests a new study in mice from the Francis Crick Institute and The Institute of Cancer Research, London
Practice-changing clinical trial reduces long-term radiotherapy side effects in women with breast cancer
Targeting or reducing the dose of radiotherapy for women with breast cancer after surgery can substantially reduce the side effects they experience, a large-scale clinical trial has shown.
HIFU: using ultrasound to heat and destroy tumours
Ultrasound has been used to detect cancer inside the body for over 70 years. But what if it could be used to treat cancer too? Conor McKeever, our Science Communications Officer, introduces an exciting technology developed by ICR scientists that does just that.
ICR celebrates Royal Society of Chemistry blue plaques for cancer drug discovery
The ICR has been recognised for its many successes in drug discovery through the award of blue plaques in Sutton and Chelsea under the Royal Society of Chemistry’s Chemical Landmark scheme.
Giving birth increases women’s breast cancer risk in the short term
Younger women who have recently had a child may have a higher risk of breast cancer than their peers of the same age who do not have children.
Immunotherapy appeal raises over £80,000 for our research
Thanks to the generosity of our donors, we have raised over £80,000 to help fund our cutting-edge work in immunotherapy through a fundraising appeal.
Targeted drug – palbociclib – stops tumour growth in patients with early breast cancer
Adding a new targeted therapy to hormone therapy halts the growth of tumour cells in women with early-stage breast cancer, new research shows.
Carols from Chelsea 2018: Christmas season starts in style with carol service for cancer research
Some famous faces from stage and screen came together to mark the start of the festive season and support the ICR at our exclusive carol service.
Making it count – the real life stories of people benefiting from innovative new cancer treatments
We are in an exciting time in cancer research, with many researchers believing we are at the tipping point in cancer treatment, and moving towards truly personalised treatment plans for patients.
New cancer drugs taking longer to reach NHS patients
NHS patients are waiting longer for new cancer drugs because of delays in taking them through clinical trials and getting them approved for use, a major new analysis of regulatory data reveals.
Scientific achievements of 2018
We've selected a range of discoveries from 2017/18 – chosen because they illustrate the quality and breadth of our basic, translational and clinical research and our ambitions under the ICR's research strategy.
Immunotherapy keeps some patients with advanced head and neck cancer alive for more than three years
A new immunotherapy can greatly extend the lives of a proportion of people with advanced head and neck cancer, with some living for three years or more, a major new clinical trial reports.